- Home
- ZH vs CYRX Comparison
ZH vs CYRX Comparison
Compare ZH & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZH
- CYRX
- Stock Information
- Founded
- ZH 2011
- CYRX 1999
- Country
- ZH China
- CYRX United States
- Employees
- ZH N/A
- CYRX N/A
- Industry
- ZH Business Services
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZH Consumer Discretionary
- CYRX Health Care
- Exchange
- ZH Nasdaq
- CYRX Nasdaq
- Market Cap
- ZH 421.4M
- CYRX 438.7M
- IPO Year
- ZH 2021
- CYRX N/A
- Fundamental
- Price
- ZH $5.01
- CYRX $9.85
- Analyst Decision
- ZH Strong Buy
- CYRX Strong Buy
- Analyst Count
- ZH 1
- CYRX 10
- Target Price
- ZH $4.70
- CYRX $11.70
- AVG Volume (30 Days)
- ZH 417.0K
- CYRX 562.2K
- Earning Date
- ZH 08-27-2025
- CYRX 11-06-2025
- Dividend Yield
- ZH N/A
- CYRX N/A
- EPS Growth
- ZH N/A
- CYRX N/A
- EPS
- ZH 0.22
- CYRX 1.35
- Revenue
- ZH $439,821,184.00
- CYRX $237,879,000.00
- Revenue This Year
- ZH N/A
- CYRX N/A
- Revenue Next Year
- ZH $7.46
- CYRX $9.08
- P/E Ratio
- ZH $22.66
- CYRX $7.40
- Revenue Growth
- ZH N/A
- CYRX 24.93
- 52 Week Low
- ZH $3.13
- CYRX $4.58
- 52 Week High
- ZH $6.32
- CYRX $10.46
- Technical
- Relative Strength Index (RSI)
- ZH 60.50
- CYRX 63.24
- Support Level
- ZH $4.64
- CYRX $8.13
- Resistance Level
- ZH $4.90
- CYRX $10.46
- Average True Range (ATR)
- ZH 0.24
- CYRX 0.54
- MACD
- ZH 0.01
- CYRX 0.09
- Stochastic Oscillator
- ZH 75.44
- CYRX 73.82
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.